AAAAAA

   
Results: 1-9 |
Results: 9
Effects of transmyocardial revascularization on myocardial perfusion and systolic function assessed by nuclear and magnetic resonance imaging methods
Authors: Aaberge, L Rootwelt, K Smith, HJ Nordstrand, K Forfang, K
Citation: L. Aaberge et al., Effects of transmyocardial revascularization on myocardial perfusion and systolic function assessed by nuclear and magnetic resonance imaging methods, SC CARDIOVA, 35(1), 2001, pp. 8-13
Myocardial laser revascularization in the year 2000 as seen by a Norwegianspecialist panel - The process of evaluating and implementing new methods in clinical practice
Authors: Wiseth, R Forfang, K Ilebekk, A Myhre, KI Nordrehaug, JE Sorlie, D
Citation: R. Wiseth et al., Myocardial laser revascularization in the year 2000 as seen by a Norwegianspecialist panel - The process of evaluating and implementing new methods in clinical practice, SC CARDIOVA, 35(1), 2001, pp. 14-18
Interaction between chemokines and oxidative stress: Possible pathogenic role in acute coronary syndromes
Authors: Aukrust, P Berge, RK Ueland, T Aaser, E Damas, JK Wikeby, L Brunsvig, A Muller, F Forfang, K Froland, SS Gullestad, L
Citation: P. Aukrust et al., Interaction between chemokines and oxidative stress: Possible pathogenic role in acute coronary syndromes, J AM COL C, 37(2), 2001, pp. 485-491
Late medical complications disease and fatigue in Hodgkin's disease survivors
Authors: Knobel, H Loge, JH Lund, MB Forfang, K Nome, O Kaasa, S
Citation: H. Knobel et al., Late medical complications disease and fatigue in Hodgkin's disease survivors, J CL ONCOL, 19(13), 2001, pp. 3226-3233
Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris - Clinical results from the Norwegian randomized trial
Authors: Aaberge, L Nordstrand, K Dragsund, M Saatvedt, K Endresen, K Golf, S Geiran, O Abdelnoor, M Forfang, K
Citation: L. Aaberge et al., Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris - Clinical results from the Norwegian randomized trial, J AM COL C, 35(5), 2000, pp. 1170-1177
Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: Results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES)
Authors: Jorgensen, B Simonsen, S Endresen, K Forfang, K Vatne, K Hansen, J Webb, J Buller, C Goulet, G Erikssen, J Thaulow, E
Citation: B. Jorgensen et al., Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: Results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES), J AM COL C, 35(3), 2000, pp. 592-599
Physiologic response to gain and loss in coronary minimal luminal diameterin patients treated with coronary angioplasty: Prediction of restenosis onthe basis of exercise capacity
Authors: Jorgensen, B Simonsen, S Endresen, K Forfang, K Egeland, T Thaulow, E
Citation: B. Jorgensen et al., Physiologic response to gain and loss in coronary minimal luminal diameterin patients treated with coronary angioplasty: Prediction of restenosis onthe basis of exercise capacity, AM HEART J, 139(3), 2000, pp. 482-490
Luminal loss and restenosis after coronary angioplasty - The role of lipoproteins and lipids
Authors: Jorgensen, B Simonsen, S Endresen, K Forfang, K Egeland, T Hostmark, AT Thaulow, E
Citation: B. Jorgensen et al., Luminal loss and restenosis after coronary angioplasty - The role of lipoproteins and lipids, EUR HEART J, 20(19), 1999, pp. 1407-1414
Enhanced levels of soluble and membrane-bound CD40 ligand in patients withunstable angina - Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
Authors: Aukrust, P Muller, F Ueland, T Berget, T Aaser, E Brunsvig, A Solum, NO Forfang, K Froland, SS Gullestad, L
Citation: P. Aukrust et al., Enhanced levels of soluble and membrane-bound CD40 ligand in patients withunstable angina - Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes, CIRCULATION, 100(6), 1999, pp. 614-620
Risultati: 1-9 |